Practical Approaches to the Management of Osteoporosis

Scroll to the bottom of page to listen to the podcast

Program Overview:

Osteoporosis-related fractures pose significant quality of life and economic burdens. However, prominent risk factors are frequently overlooked and osteoporosis continues to be under recognized by patients and primary care clinicians alike. A number of agents with varying mechanisms of action are available for the prevention and management of osteoporosis. Patient and clinician discussions of the merits and drawbacks of treatment paradigms are paramount since long-term management strategies are required and polypharmacy is common in this population. Compliance and persistence with pharmacotherapy are frequently low and many patients prematurely discontinue therapy with negative consequences on bone mineral density (BMD).

Practical Approaches to the Management of Osteoporosis will underscore the importance of osteoporosis screening, risk-benefit analysis, treatment selection, and long-term patient adherence. Evidence-based data on available and emerging pharmacotherapies will be presented to assist with treatment initiation, efficacy issues, and long-term safety assessment. Clinical challenges such as use and interpretation of BMD testing, patient adherence, and treatment failure will also be addressed. The didactic presentation will be complemented by a case presentation and review of clinical resource tools.

Learning Objectives:

After completing this activity, the participant will be able to

• Assess for risk factors of osteoporosis to identify which patients require additional screening
• Relate the application of available and emerging treatments for osteoporosis

Accreditation/Designation Statement:

Primary Care Network, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Primary Care Network designates this educational activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Target Audience:

This activity is targeted to all physicians and other healthcare professionals who treat patients with osteoporosis.

Release Date: July 29, 2009
Expiration Date: July 29, 2010

Medium: Podcast

Acknowledgement of Commercial Support:

This activity was developed from the live Best Practices in Primary Care™ program held in Los Angeles, California, on May 28, 2009, and is funded by Amgen Inc.

Method of Participation:

To receive CME credit for this activity, you need to listen to the program. Upon finishing the podcast, complete the post-test and evaluation and fill out all required personal information. To receive your CME certificate you will need to pass the post-test with 70% accuracy or better.

Post-test and Evaluation:

After completing this activity, click on the Post-test button at the end of the program. If you receive less than 70% on the post-test, you will be returned to the beginning of the activity to review the presentation again. Upon successful completion of the post-test, you will be asked to fill out a program evaluation form and prompted to print your CME certificate.

Statement of Disclosure and Independence:

It is the policy of Primary Care Network, Inc. to ensure all its sponsored educational activities are planned, developed, and conducted in accordance with the ACCME’s Essential Areas and Policies. In accordance with ACCME requirements, Primary Care Network has Conflict of Interest and Disclosure Policies that are designed to ensure that Primary Care Network sponsored educational activities are fair balanced, independent, evidence-based and based on scientific rigor.

Primary Care Network’s Resolution of Personal Conflicts of Interest (COI) Policy aims to ensure that all conflicts are resolved prior to the activity, content is developed and presented free of commercial bias, and is in the interest of promoting improvements or quality in healthcare. All individuals who are in a position to influence and/or control content of a Primary Care Network sponsored activity are required to disclose to the participants any real or apparent conflict of interest related to the activity. The educational content is also reviewed for independence and content validation by an independent external clinical reviewer and internal clinical reviewer. Independence is also monitored through the activity and overall program evaluation process.

The opinions, ideas, recommendations, and perspectives expressed in the accompanying presentations at this Primary Care Education program are those of the program authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations or perspectives of their affiliated institutions, Primary Care Network, Primary Care Education, Advisory Boards and Consultants, or the activity’s commercial supporters.

Planning Committee and Disclosures:

Jonathan D. Adachi, MD, FRCPC
Professor of Rheumatology, McMaster University
Hamilton, Ontario

Dr. Adachi is on the speaker’s bureau for Amgen, Eli Lilly, GlaxoSmithKline, Hoffman La Roche, Merck, Novartis, sanofi-aventis, Wyeth, and Procter & Gamble. He is on the advisory board for Amgen, Eli Lilly, GlaxoSmithKline, Hoffman La Roche, Merck, Novartis, sanofi-aventis, Wyeth, and Procter & Gamble. He is a consultant for Amgen, Eli Lilly, GlaxoSmithKline, Hoffman La Roche, Merck, Novartis, sanofi-aventis, Wyeth, and Procter & Gamble. He has received research grants from Amgen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Hoffman La Roche, Merck, Novartis, sanofi-aventis, Wyeth, and Procter & Gamble.

Bess Dawson-Hughes, MD
Professor of Medicine & Director of the Bone Metabolism Laboratory
Tufts University School of Medicine
Boston, MA

Dr. Dawson-Hughes is a consultant for Amgen.

Christine Simonelli, MD
Associate Clinical Professor of Medicine, University of Minnesota
Director, Osteoporosis Care
HealthEast Clinics
St. Paul, MN

Dr. Simonelli is on the data safety board for Amgen. She is on the speaker’s bureau for Ely Lilly, GlaxoSmithKline, and Hoffman La Roche. She has received research grants from Eli Lilly, Novartis, and Hoffman La Roche.

Susan Randall, RN, MSN, CFNP
National Osteoporosis Foundation
Washington, DC

Ms. Randall has no relevant financial relationships to disclose.

Audrey E. Shively, MSHSE, CHES
Manager, Research and Professional Education
National Osteoporosis Foundation
Washington, DC

Ms. Shively has no relevant financial relationships to disclose.

Natasha A. Mitchner, PhD
Scientific Director, DIME
Chicago, IL

Dr. Mitchner is a stock shareholder for Pfizer.

Karen Catino
Senior Program Manager, DIME
Chicago, IL

Ms. Catino has no relevant financial relationships to disclose.

Faculty and Disclosures:

Christine Simonelli, MD
Associate Clinical Professor of Medicine, University of Minnesota
Director, Osteoporosis Care
HealthEast Clinics
St. Paul, MN

Dr. Simonelli is on the data safety board for Amgen. She is on the speaker’s bureau for Ely Lilly, GlaxoSmithKline, and Hoffman La Roche. She has received research grants from Eli Lilly, Novartis, and Hoffman La Roche.    

Review Committee Disclosure:

In accordance with PCN policy, all content is reviewed by external independent peer reviewers for balance, objectivity, and commercial bias.  The peer reviewers, staff, and other individuals who control content have no relevant financial relationships to disclose.

Unlabeled Use Declaration:

During their presentation(s), faculty may discuss an unlabeled use or an investigational use not approved for a commercial product. Each faculty member is required to disclose this information to the audience when referring to an unlabeled or investigational use.

Listen to Podcast

When finished, click here to take the Post-test

Take the post-test to receive your CME certificate